Bevacizumab for first line treatment of Wet Age Related Macular Degeneration policy

The purpose of this policy is to ensure that NHS Kernow fund treatment only for clinically effective interventions delivered to the right patients. It sets out the treatments deemed to be of insufficient priority to justify funding from the available fixed budget.

Individual Funding Requests Policy

A six month trial of the FreeStyle Libre is routinely commissioned for patients with type 1 diabetes attending specialist secondary care clinics for their diabetes, and who have been assessed by their specialist to meet one of the criteria outlined below. This would be continued if the patient demonstrates the applicable continuation criteria at a six month clinic assessment. This trial process needs to be fully explained to the patient at the commencement of the trial.